Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonists

Details for Australian Patent Application No. 2005306325 (hide)

Owner King Pharmaceuticals Research & Development Inc.

Inventors Moorman, Allan; Leung, Edward; Borea, Pier Andrea; Merighi, Stefania; Baraldi, Pier Giovanni; MacLennan, Stephen

Agent Pizzeys

Pub. Number AU-A-2005306325

PCT Pub. Number WO2006/055970

Priority 60/630,555 22.11.04 US

Filing date 22 November 2005

Wipo publication date 26 May 2006

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/055970 Priority application(s): WO2006/055970

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306330-Erectable shelter with three way awning

2005306321-Pipe clamp with improved fastener